Not Signed In -
Leukemia |
General leukemia; Leukemia cancer |
Leukemia or leukaemia (see spelling differences) is a cancer of the blood or bone marrow characterized by an abnormal proliferation of blood cells, usually white blood cells (leukocytes). It is part of the broad group of diseases called hematological neoplasms. Symptoms Damage to the bone marrow, by way of displacing the normal marrow cells with increasing numbers of malignant cells, results in a lack of blood platelets, which are important in the blood clotting process. This means peop ...
Wikipedia - [full article]
Leukemia Clinical Trials
- Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00186823 - Active, not recruiting
Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Hemoglobinuria, Paroxysmal
- VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00049686 - Active, not recruiting
acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Hairy Cell Leukemia; myelodysplastic and myeloproliferative disease; ...
- Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
ClinicalTrials.gov Identifier: NCT00002768 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
- Sorafenib in Treating Patients With Relapsed or Refractory Leukemia
ClinicalTrials.gov Identifier: NCT00131989 - Active, not recruiting
adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
Leukemia, Myeloid; Leukemia, Myeloid, Chronic
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006045 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
ClinicalTrials.gov Identifier: NCT00171223 - Active, not recruiting
Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
- An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
ClinicalTrials.gov Identifier: NCT00171249 - Active, not recruiting
Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
- Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia
ClinicalTrials.gov Identifier: NCT00002832 - Active, not recruiting
Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Lymphocytic
- Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006084 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00278213 - Active, not recruiting
Leukemia
- Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
ClinicalTrials.gov Identifier: NCT00002534 - Active, not recruiting
childhood acute myeloid leukemia in remission; adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; ...
- High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002788 - Active, not recruiting
stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
- Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
- Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00019409 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
- Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005801 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005945 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
- Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003758 - Active, not recruiting
acute leukemia; childhood cancer; hematopoietic/lymphoid cancer; Cancer; Leukemia; cellular diagnosis, childhood acute myeloid leukemia; ...
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002704 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
- Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients with Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00086099 - Active, not recruiting
Leukemia; Acute Myeloid Leukemia
- Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002925 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00004245 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003829 - Active, not recruiting
stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
- PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004217 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003190 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00313079 - Recruiting
Leukemia; Leukemia, Lymphocytic; Leukemia, B-Cell; Leukemia, B-Cell, Acute
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
ClinicalTrials.gov Identifier: NCT00025545 - Active, not recruiting
adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ...
- Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00072007 - Active, not recruiting
B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
- Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005863 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00003700 - Active, not recruiting
L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
- Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004215 - Active, not recruiting
Anemia; adult acute poorly differentiated monocytic leukemia (M5a); adult acute myeloblastic leukemia with maturation (M2); ...
- STI571 in Treating Patients With Recurrent Leukemia
ClinicalTrials.gov Identifier: NCT00004932 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
- Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002592 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00006020 - Active, not recruiting
recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
Leukemia
- Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00112853 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
ClinicalTrials.gov Identifier: NCT00012376 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Fludarabine Followed by Campath-1H in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00004857 - Active, not recruiting
stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
- Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00011934 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Molecular Epidemiology of Childhood Leukemia in Northern and Central California
ClinicalTrials.gov Identifier: NCT00015587 - Recruiting
Leukemia; Acute Myelocytic Leukemia; Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00061945 - Active, not recruiting
B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
- Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00321880 - Active, not recruiting
Fatigue; Leukemia; Psychosocial Effects/Treatment
- Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00053144 - Active, not recruiting
Myeloid Leukemia
- Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093418 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00085007 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- 3-AP and Cytarabine in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00064090 - Active, not recruiting
acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease
- Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00005802 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia
- Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
ClinicalTrials.gov Identifier: NCT00008190 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
- Cytarabine and Daunorubicin with Or Without Gemtuzumab Ozogamicin in Treating Older Patients with Acute Myeloid Leukemia Or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00121303 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00246662 - Active, not recruiting
Leukemia, Lymphocytic, Acute; Leukemia, Nonlymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
- VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
ClinicalTrials.gov Identifier: NCT00083187 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ...
- SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00098826 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; acute undifferentiated leukemia; adult acute erythroid leukemia; ...
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
- Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003870 - Active, not recruiting
adult acute lymphoblastic leukemia in remission; recurrent adult acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia; ...
- Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002838 - Active, not recruiting
stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia
- Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
ClinicalTrials.gov Identifier: NCT00003746 - Active, not recruiting
untreated hairy cell leukemia; progressive hairy cell leukemia, initial treatment; Prolymphocytic Leukemia
- Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003729 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
- Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003248 - Active, not recruiting
stage II chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; stage IV chronic lymphocytic leukemia; ...
- Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
ClinicalTrials.gov Identifier: NCT00001637 - Active, not recruiting
Chronic Lymphocytic Leukemia; Graft vs Host Disease; Leukemia; Myelodysplastic Syndrome; Myeloid Leukemia
- Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
- High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002945 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ...
- Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00004034 - Active, not recruiting
L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ...
- Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002789 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
ClinicalTrials.gov Identifier: NCT00098436 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- BMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00110097 - Active, not recruiting
blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003671 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
- Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
- Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00003056 - Active, not recruiting
Lymphoma; Leukemia
- Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia or With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003885 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003764 - Active, not recruiting
stage 0 chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
- Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00004898 - Active, not recruiting
Leukemia; Lymphoma
- Fludarabine and Rituximab Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00098670 - Active, not recruiting
B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
- BMS-354835 versus Imatinib Mesylate in Subjects with Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00103844 - Active, not recruiting
Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia
- A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00076401 - Active, not recruiting
Leukemia; Leukemia, Lymphocytic, Chronic
- Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00091234 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00017342 - Active, not recruiting
recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00070538 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
- Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
ClinicalTrials.gov Identifier: NCT00002554 - Active, not recruiting
recurrent adult acute myeloid leukemia; adult acute myeloid leukemia in remission
- Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002778 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
- Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
Leukemia
- Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
- Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
ClinicalTrials.gov Identifier: NCT00005622 - Active, not recruiting
acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
- Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00009698 - Active, not recruiting
childhood acute myeloid leukemia in remission; recurrent childhood acute myeloid leukemia; ...
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
Resources
- Acute Lymphoblastic Leukemia in Children (National Cancer Institute)
- Acute Lymphoblastic Leukemia in Children (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page